USMLE Step 2 CK: Psychiatry—Mood Disorders, MDD, Bipolar, Suicide Risk, Pharmacotherapy Selection

What This Is and Why It Matters for USMLE

Mood disorders, including Major Depressive Disorder (MDD), Bipolar Disorder, and Suicide Risk, are high-yield for Step 1 and Step 2 CK, and moderately tested on Step 3. These conditions frequently appear in clinical vignettes and are crucial for diagnosing and managing patients with complex psychiatric and medical comorbidities.

High-Yield Facts (What You Must Memorize)

Pathophysiology (Step 1)

• Serotonin and dopamine dysregulation in mood disorders
• Genetic predisposition (e.g., BDNF gene)
• Hormonal influences (e.g., thyroid dysfunction)

Classic Presentation and Physical Exam Findings (Step 2 CK)

• Depressed mood, anhedonia, and loss of interest in MDD
• Manic episodes with euphoria, increased energy, and irritability in Bipolar Disorder
• Suicidal ideation and behavior in all mood disorders

Diagnostic Approach (Labs, Imaging)

• Complete blood count (CBC) and electrolyte panel for MDD
• Lithium levels and thyroid function tests for Bipolar Disorder
• No specific lab tests for Suicide Risk; focus on psychiatric evaluation

First-Line Treatment and Management (Step 2 CK, Step 3)

• Selective serotonin reuptake inhibitors (SSRIs) for MDD
• Mood stabilizers (e.g., lithium, valproate) for Bipolar Disorder
• Crisis intervention and suicide prevention for Suicide Risk

Red Flags, Complications, and Follow-Up

• Suicidal ideation and behavior require immediate attention
• Mood stabilizers can cause liver enzyme elevation and weight gain
• Regular follow-up for mood disorder management

Clinical Pearls & Buzzwords

• "Bipolar I" vs. "Bipolar II": different treatment approaches
• "Double depression": MDD with dysthymia
• "Suicidal ideation": requires immediate attention and safety planning

Step-by-Step Clinical Reasoning

1. Identify the syndrome or presentation (e.g., MDD, Bipolar Disorder, Suicide Risk)
2. Generate a differential (most likely and must-not-miss) Don't miss suicidal ideation in all mood disorders
3. Order appropriate initial tests (e.g., CBC, electrolyte panel, thyroid function tests)
4. Interpret results and adjust treatment plan accordingly
5. Initiate treatment and monitoring (e.g., SSRI, mood stabilizer, crisis intervention)

Common Mistakes & Exam Traps

• The mistake: Failing to recognize suicidal ideation in MDD
• Why it happens: Rushing through the question or misreading the patient's presentation
• How to avoid it: Slow down and carefully read the patient's symptoms and history
• Exam board insight: Examiners penalize missing suicidal ideation as a critical error
• The mistake: Prescribing a mood stabilizer without checking lithium levels
• Why it happens: Misunderstanding the treatment approach or rushing through the question
• How to avoid it: Verify the patient's lithium levels before prescribing a mood stabilizer
• Exam board insight: Examiners expect you to consider potential side effects and interactions

How It’s Tested on USMLE

Step 1:

• Basic science vignette (e.g., molecular mechanism, pathology slide, pharmacology)
• Focus on pathophysiology, pharmacology, and pathology
• Example question: A 25-year-old woman presents with depressive symptoms. Which of the following neurotransmitters is most likely involved in her condition?

Step 2 CK:

• Clinical vignette (e.g., "A 45-year-old with chest pain...")
• Focus on diagnosis and next step in management
• Example question: A 35-year-old man presents with manic symptoms. Which of the following medications is most likely to be effective in treating his condition?

Step 3:

• Similar to Step 2 CK, plus prognosis, risk factors, and occasionally CCS management
• Focus on risk assessment, prognosis, and management
• Example question: A 50-year-old woman presents with recurrent depressive episodes. What is the most likely long-term outcome of her condition?

CCS (Step 3) Relevance (If Applicable)

If this topic appears in Step 3 Computer-based Case Simulations, provide a short strategy: Initial orders: Verify the patient's lithium levels and order a CBC and electrolyte panel Monitoring and follow-up: Regularly check lithium levels and monitor for side effects and interactions Common mistakes: Not ordering indicated tests or delaying treatment due to uncertainty

Practice Questions (3-5 single-best-answer)

Question 1:

A 30-year-old woman presents with depressive symptoms. Which of the following medications is most likely to be effective in treating her condition?

A) Serotonin-norepinephrine reuptake inhibitor (SNRI) B) Selective serotonin reuptake inhibitor (SSRI) C) Tricyclic antidepressant (TCA) D) Monoamine oxidase inhibitor (MAOI)

Answer:

B) Selective serotonin reuptake inhibitor (SSRI)

Explanation:

SSRIs are the first-line treatment for MDD due to their efficacy and safety profile.

Question 2:

A 40-year-old man presents with manic symptoms. Which of the following medications is most likely to be effective in treating his condition?

A) Lithium B) Valproate C) Carbamazepine D) Topiramate

Answer:

A) Lithium

Explanation:

Lithium is a mood stabilizer that is effective in treating manic episodes in Bipolar Disorder.

Question 3:

A 50-year-old woman presents with recurrent depressive episodes. What is the most likely long-term outcome of her condition?

A) Remission B) Partial remission C) Chronic depression D) Deterioration

Answer:

C) Chronic depression

Explanation:

Chronic depression is a common long-term outcome of recurrent depressive episodes.

Quick Reference Card (60-Second Summary)

• MDD: SSRIs, regular follow-up
• Bipolar Disorder: Mood stabilizers, lithium levels, regular follow-up
• Suicide Risk: Crisis intervention, safety planning, regular follow-up
• Key associations: SSRIs with MDD, mood stabilizers with Bipolar Disorder
• First-line treatments: SSRIs for MDD, mood stabilizers for Bipolar Disorder

If You Get Stuck on Test Day

• Eliminate obviously wrong answers based on patient presentation and history
• Use the "next best step" hierarchy (least invasive, most specific) to guide your management
• For Step 3 CCS: Order basic labs (e.g., CBC, electrolyte panel) and verify the patient's lithium levels

Related USMLE Topics

• Anxiety disorders: connects to benzodiazepines and SSRIs
• Substance use disorders: connects to addiction medicine and behavioral therapy
• Personality disorders: connects to psychodynamic therapy and cognitive-behavioral therapy